Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction

(2009) E. A. Nijland et al.   CLIMACTERIC

Continuing Medical Education: The Use of Estrogen Therapy in Women's Sexual Functioning (CME)

(2009) Rossella E. Nappi et al.   Journal of Sexual Medicine

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

(2009) Peter Kenemans et al.   LANCET ONCOLOGY

The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors

(2008) S. O. Skouby et al.   CLIMACTERIC

The impact of tibolone and hormone therapy on serum C-reactive protein, tumor necrosis factor-α and hepatocyte growth factor in postmenopausal women

(2008) K. Sezer Özer et al.   CLIMACTERIC

Hormone therapy and risk of myocardial infarction: a national register study

(2008) E. Lokkegaard et al.   EUROPEAN HEART JOURNAL

FSD PHARMACOTHERAPY: Tibolone and Transdermal E2/NETA for the Treatment of Female Sexual Dysfunction in Naturally Menopausal Women: Results of a Randomized Active-Controlled Trial

(2008) Esme A. Nijland et al.   Journal of Sexual Medicine

Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers

(2008) A. L. EILERTSEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Hormone replacement therapy use and the risk of stroke

(2008) Christel Renoux et al.   MATURITAS

The Effects of Tibolone in Older Postmenopausal Women

(2008) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women

(2008) P. D. Delmas et al.   OSTEOPOROSIS INTERNATIONAL